World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
6100
World Ranking
4727
National Ranking
2130

Maurizio Chiriva-Internati publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Maurizio Chiriva-Internati sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 241 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Maurizio Chiriva-Internati D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Maurizio Chiriva-Internati sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Maurizio Chiriva-Internati is affiliated with Frontiers in Immunology in Switzerland and has a substantial body of research spanning multiple disciplines within medical and biological sciences. Their work primarily focuses on Medicine and Biochemistry, Genetics and Molecular Biology, contributing notably to subfields such as Molecular Biology, Immunology, Oncology, Pulmonary and Respiratory Medicine, and Biomedical Engineering.

Their research encompasses several key topics including CAR-T cell therapy research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, vaccines and immunoinformatics approaches, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, and RNA Interference and Gene Delivery.

Maurizio Chiriva-Internati has authored research papers published across a range of scientific venues. These include:

  • "Fractal nature of human gastrointestinal system: Exploring a new era," 2023, World Journal of Gastroenterology
  • "The kidney, COVID-19, and the chemokine network: an intriguing trio," 2020, International Urology and Nephrology
  • "Investigating the Spatial Distribution of Proliferating Cells in Primary Ovarian Cancers," 2024, Discovery Medicine
  • "Prostate Cancer Microvascular Routes: Exploration and Measurement Strategies," 2023, Life
  • "Abstract LB148: Gamma delta T cells engineered with a chimeric PD-1 receptor effectively control PD-L1 positive tumors in vitro and in vivo with minimal toxicities," 2021, Cancer Research

The scientist frequently publishes in the journal Cancer Research, with a total of six publications, followed by contributions to Zenodo (CERN European Organization for Nuclear Research), World Journal of Gastroenterology, Discovery Medicine, and International Urology and Nephrology.

Maurizio Chiriva-Internati often collaborates with a consistent group of co-authors. Frequent collaborators include Fabio Grizzi, Leonardo Mirandola, Robert S. Bresalier, Gianluigi Taverna, and Mohamed A.A.A. Hegazi.

Best Publications

  • Celiac disease: From pathophysiology to treatment

    Ilaria Parzanese;Dorina Qehajaj;Federica Patrinicola;Merica Aralica

  • Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer

    Alessandro D. Santin;Paul L. Hermonat;Antonella Ravaggi;Antonella Ravaggi;Maurizio Chiriva-Internati

  • Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma

    Seah H. Lim;Zhiqing Wang;Maurizio Chiriva-Internati;Yuying Xue

  • Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma

    Maurizio Chiriva-Internati;Zhiqing Wang;Emanuela Salati;Klaus Bumm

  • Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.

    Fabio Grizzi;Barbara Franceschini;Cody Hamrick;Eldo E Frezza

  • Expression of sperm protein 17 (Sp17) in ovarian cancer

    J. Michael Straughn;Denise R. Shaw;Antonio Guerrero;Snehal M. Bhoola

  • Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells.

    Maurizio Chiriva-Internati;Yong Liu;Emanuela Salati;Weiping Zhou

  • Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

    Jose A. Figueroa;Adair Reidy;Leonardo Mirandola;Kayley Trotter

  • Human papillomavirus DNA is present in a subset of unselected breast cancers.

    Yong Liu;Vicki Klimberg;Nancy R. Andrews;Carla R. Hicks

  • Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1

    L Mirandola;L Apicella;M Colombo;Y Yu

  • Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer.

    Leonardo Mirandola;Martin J. Cannon;Everardo Cobos;Giovanni Bernardini

  • Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes

    M Colombo;L Mirandola;N Platonova;L Apicella

  • Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

    Yong Liu;Maurizio Chiriva-Internati;Fabio Grizzi;Emanuela Salati

  • Tumor vaccine for ovarian carcinoma targeting sperm protein 17

    Maurizio Chiriva-Internati;Zhiqing Wang;Emanuela Salati;Patrick Timmins

  • Expression of Surface Antigens During the Differentiation of Human Dendritic Cells vs Macrophages from Blood Monocytes in vitro

    Alessandro D. Santin;Paul L. Hermonat;Antonella Ravaggi;Maurizio Chiriva-Internati

  • Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24

    Maurizio Chiriva-Internati;Yong Liu;Jon A. Weidanz;Fabio Grizzi

  • Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies.

    Zhiqing Wang;Yana Zhang;Haichao Liu;Emanuela Salati

  • Infection, replication, and cytopathology of human papillomavirus type 31 in trophoblasts.

    Hong You;Yong Liu;Nalini Agrawal;C.Krishna Prasad

  • A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1.

    Li Yumin;Chen Hao;Li Xun;Zhou Wence

  • Radiation-Enhanced Expression of E6/E7 Transforming Oncogenes of Human Papillomavirus-16 in Human Cervical Carcinoma

    Alessandro D. Santin;Paul L. Hermonat;Antonella Ravaggi;Antonella Ravaggi;Maurizio Chiriva-Internati;Maurizio Chiriva-Internati

  • Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk.

    Maurizio Chiriva-Internati;Zhiqing Wang;Yuying Xue;Klaus Bumm

Frequent Co-Authors

W. Martin Kast
W. Martin Kast University of Southern California
Martin J. Cannon
Martin J. Cannon University of Arkansas for Medical Sciences
Alessandro D. Santin
Alessandro D. Santin Yale University
Jawahar L. Mehta
Jawahar L. Mehta University of Arkansas for Medical Sciences
Adrian Bot
Adrian Bot MannKind Corporation (United States)
Soldano Ferrone
Soldano Ferrone Harvard University
Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center
Isabella Dalle-Donne
Isabella Dalle-Donne University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields such as Psychiatric Mental Health Nurse Practitioner (PMHNP) programs can offer valuable opportunities for specialization. Many students seek out top pmhnp programs known for strong clinical placement rates, which are crucial for hands-on experience and career readiness.

Cost is often a significant factor when choosing a program. Fortunately, numerous affordable pmhnp programs make advanced nursing education accessible without sacrificing quality. This balance allows future practitioners to enter the workforce with minimal debt.

Graduates with advanced nursing degrees, such as a Doctor of Nursing Practice (DNP), can expect competitive salaries depending on their state. Reviewing the doctor of nursing practice salary data helps candidates understand earning potential and plan their careers accordingly.

Additionally, registered nurses looking to deepen their expertise might consider programs that facilitate transitioning roles. Resources like the fnp to acute care np bridge program highlight pathways for family nurse practitioners aiming for acute care specialization, broadening their scope and impact.

Best Scientists Citing Maurizio Chiriva-Internati

Trending Scientists

Recently Published Articles